Galaxy Medicare IPO Subscription Status
Galaxy Medicare IPO was subscribed 0.47 times on the first day of bidding, till 5:00 PM on 10 September 2025.
- Qualified Institutional Buyers (QIB): Subscribed 1.00x
- Non-Institutional Investors (NII): Subscribed 0.66x
- Retail Individual Investors (RII): Subscribed 0.33x
By the end of day one, the company received 18,52,000 bids against the total 39,24,000 shares available for offer. The IPO therefore achieved an overall subscription of 0.47x on day 1, indicating room for more retail participation in the upcoming days.
About Galaxy Medicare
Established in 1992, Galaxy Medicare Limited is a leading Indian manufacturer and exporter of medical devices, POP (Plaster of Paris) bandages, and surgical dressings, with over three decades of industry experience.
- The company owns 27 registered trademarks, including well-recognized names such as POP BAND, POP CAST, G CAST, and CARETAPE, strengthening its brand presence in both domestic and international markets.
- Galaxy Medicare supplies its products to government health departments, reputed hospitals, and private healthcare companies, creating a strong and reliable distribution network across India.
- The firm employs around 190 skilled professionals and emphasizes continuous product innovation, strict quality control, and cost efficiency to meet global medical standards.
- Its advanced quality-control unit is equipped to test every product for design, durability, and finish, ensuring internationally accepted manufacturing practices.
Financial Performance
- Revenue: ₹40.27 crore in FY 2025 compared to ₹36.94 crore in FY 2024, showing steady top-line growth.
- Net Profit: ₹3.37 crore in FY 2025 versus ₹3.71 crore in FY 2024, reflecting stable profitability despite industry competition and input cost variations.
- The company continues to maintain healthy margins supported by efficient operations and a diversified customer base.
Galaxy Medicare IPO GMP
As of Wednesday, 10 September 2025, the Grey Market Premium (GMP) stood at ₹1 per share.
This implies the IPO shares were trading at around ₹55, a ₹1 premium over the issue price of ₹54.
Although the initial premium is modest, market experts note that GMP can fluctuate based on broader market sentiment and subscription momentum in the coming days.
